Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A04 ANTIEMETICS AND ANTINAUSEANTS
A04A ANTIEMETICS AND ANTINAUSEANTS
A04AD Other antiemetics
A04AD12 Aprepitant
D02968 Aprepitant (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antiemetics
Emetogenic Therapy Adjuncts
Aprepitant
D02968 Aprepitant (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
23 Digestive organ agents
239 Miscellaneous
2391 Antiemetics
D02968 Aprepitant (JAN/USP/INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01762 Antiemetic
DG00066 Aprepitant
D02968 Aprepitant
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00066 Aprepitant
D02968 Aprepitant
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
DG00066 Aprepitant
D02968 Aprepitant
Metabolizing enzyme inducer
DG02886 CYP2C9 inducer
DG00066 Aprepitant
D02968 Aprepitant
DG02853 CYP3A/CYP3A4 inducer
DG01635 CYP3A4 inducer
DG00066 Aprepitant
D02968 Aprepitant
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Tachykinin
TACR1 (NK1R)
D02968 Aprepitant (JAN/USP/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02968
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02968
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02968
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02968
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02968
Prodrugs [br08324.html]
D02968
Prodrugs [br08324.html]
C21555
